Cellectar Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Cellectar Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Cellectar Biosciences Inc
Rating: 1.34991675
Author: Trendlyne DVM scores

about

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid d...

3.74 -0.30 (-7.43%)

81.85% Fall from 52W High

194.8K

XNAS Volume

High vol.+gain this week

XNAS 14 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

10.2 / 100

Technically Neutral

43.8 / 100

No estimates available

Cellectar Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cellectar Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid d...

81.85% Fall from 52W High

High vol.+gain this week

SWOT Analysis

Cellectar Biosciences Inc Live Price Chart